Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome

Status unconfirmed · Phase 2

Conditions studied: Myelodysplastic Syndromes

In brief

RATIONALE: Amifostine may be effective in helping blood counts return to normal in treating patients with myelodysplastic syndrome. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with advanced myelodysplastic syndrome.

Key facts

Study ID

NCT00003123

Run by

Providence Hospital

People needed

36

Starts

1997-08-01

Last updated by the study team

2013-11-06

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Osteopathic Medical Oncology and Hematology, P.C. — Clinton Township, Michigan, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• Garden City Hospital — Garden City, Michigan, United States
• Marquette General Hospital — Marquette, Michigan, United States
• Providence Hospital Cancer Center — Southfield, Michigan, United States
• Cleveland Clinic Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.